The field of pharmaceuticals is witnessing a transformative phase with the introduction of large-volume injectors (LVIs), which promise to be Game-changers in administering high doses of medication. At the heart of this evolution, the discussion led by Mark DeStefano at Pharmapack Europe 2024
Breakthrough Study in HCV Treatment Findings from the University at Buffalo A groundbreaking study from the University at Buffalo, featured in JAMA, has made a compelling case for telemedicine as a game-changer in treating Hepatitis C (HCV) within opioid treatment programs (OTPs). The research
The transformation of emergency medical services (EMS) has been profoundly influenced by telemedicine, revolutionizing the way emergency care is delivered. With the challenge of integrating technology into patient management, telemedicine's role in EMS highlights a fascinating development. The
Telemedicine: A Game-Changer in HCV Healthcare Reaching the Underserved Populations In a groundbreaking study led by Andrew Talal, MD, telemedicine has demonstrated a remarkable impact on the treatment accessibility for individuals with hepatitis C virus (HCV) in the context of opioid use disorder.
Praia Health, a pioneering digital health entity, has emerged from the innovative ecosystem of Providence with a mission to redefine the healthcare domain. The company has successfully secured a substantial $20 million in Series A funding, setting the stage for a significant impact on digital
The digital health landscape is transforming with wearable biosensor tech leading the charge. Biolinq, a California-based pioneer, has spotlighted this evolution with a striking $58 million investment boost. This funding, shepherded by Alpha Wave Ventures and supported by Niterra and Pegasus Tech
